ArticleTransplantation2019
Eculizumab as Primary Therapy for Active Antibody-mediated Rejection of Renal Allografts: A Matter of Timing, Severity, and Donor-specific Antibodies.
Mark HaasPubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it